Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Harvard Business School
Cantor Fitzgerald
Citi
McKinsey
Chinese Patent Office
UBS
Julphar
Express Scripts

Generated: December 13, 2018

DrugPatentWatch Database Preview

Patent: 9,279,001

« Back to Dashboard

Summary for Patent: 9,279,001
Title:Injection paradigm for administration of botulinum toxins
Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
Inventor(s): Turkel; Catherine C. (Newport Coast, CA), Aurora; Sheena K. (Seattle, WA), Brin; Mitchell F. (Newport Beach, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:13/863,522
Patent Claim Types:
see list of patent claims
Use;

Details for Patent 9,279,001

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merz Pharms XEOMIN incobotulinumtoxina INJECTABLE; INJECTION 125360 002 2010-07-30 ➤ Try a Free Trial Allergan, Inc. (Irvine, CA) ➤ Try a Free Trial RX search
Merz Pharms XEOMIN incobotulinumtoxina INJECTABLE; INJECTION 125360 001 2010-07-30 ➤ Try a Free Trial Allergan, Inc. (Irvine, CA) ➤ Try a Free Trial RX search
Ipsen Biopharm Ltd DYSPORT abobotulinumtoxina INJECTABLE; INJECTION 125274 002 2009-04-29 ➤ Try a Free Trial Allergan, Inc. (Irvine, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Johnson and Johnson
Harvard Business School
Cerilliant
AstraZeneca
Accenture
Express Scripts
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.